XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Business (Details)
9 Months Ended
Sep. 15, 2025
$ / shares
Jul. 21, 2025
$ / shares
Mar. 25, 2025
USD ($)
shares
Mar. 24, 2025
Feb. 05, 2025
USD ($)
Feb. 03, 2025
EUR (€)
Jan. 21, 2025
$ / shares
Sep. 30, 2025
USD ($)
Business [Line Items]                
Number of consecutive business days 10 years 10 days         30 days  
Bid price per share | $ / shares $ 1 $ 1         $ 1  
Total purchase price | €           € 3,000,000    
Paid amount         $ 2,756,000      
Payment credit to purchase         $ 250,000      
Percentage of outstanding shares       10.00%        
Development pay               $ 200,000,000
Percentage of net sales               3.00%
Common Stock [Member]                
Business [Line Items]                
Upfront payment     $ 3,500,000          
Shares issued | shares     3,017,420          
Relmada Therapeutics, Inc [Member]                
Business [Line Items]                
Number of consecutive business days   10 days            
Bid price per share | $ / shares   $ 1